CVC Drops, Mankind Rises, Revolution Medicines Drops on Merck News
On this episode of Stock Movers:- CVC (CVC) shares drop after the company agreed to buy Marathon Asset Management in a cash and equity transaction with a base consideration valued at as much as $1.2 billion.- Mankind (MNKD) shares rise after the FDA approved an update to the company’s inhaled insulin, revising recommendations for the starting mealtime dosage.- Revolution Medicines (RVMD) shares drop on news Merck is no longer in talks to acquire biotech firm.See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.